BRIEF published on 01/10/2025 at 13:05, 1 year 1 month ago Lumira Ventures Promotes Suman Rao to Principal Healthcare Innovation Venture Capital Lumira Ventures Suman Rao Principal Promotion
BRIEF published on 01/10/2025 at 13:05, 1 year 1 month ago Lumira Ventures promeut Suman Rao au poste de directeur Capital-risque Lumira Ventures Innovation Dans Le Domaine De La Santé Suman Rao Promotion Principale
PRESS RELEASE published on 01/10/2025 at 13:00, 1 year 1 month ago Lumira Ventures Announces Promotion of Suman Rao to Principal Lumira Ventures promotes Suman Rao, Ph.D., to Principal, recognizing her contributions to healthcare innovation. Read more about her journey and achievements Healthcare Innovation Venture Capital Lumira Ventures Biomedical Suman Rao
BRIEF published on 06/26/2024 at 13:05, 1 year 7 months ago Lumira Ventures Promotes Nikhil Thatte to Partner Promotion Life Sciences Lumira Ventures Healthcare Investment Nikhil Thatte
BRIEF published on 06/26/2024 at 13:05, 1 year 7 months ago Lumira Ventures promeut Nikhil Thatte comme partenaire Promotion Lumira Ventures Investissement Dans La Santé Sciences De La Vie Nikhil Thatte
PRESS RELEASE published on 06/26/2024 at 13:00, 1 year 7 months ago Lumira Ventures Announces Promotion of Nikhil Thatte to Partner Lumira Ventures promotes Nikhil Thatte to Partner in recognition of his exceptional contributions to healthcare innovation. Nikhil's strategic insights drive firm's success and partnerships Life Sciences Healthcare Innovation Lumira Ventures Investment Firm Nikhil Thatte
BRIEF published on 04/02/2024 at 13:05, 1 year 10 months ago Lumira Ventures Invests in Nocion Therapeutics to Advance Chronic Cough Treatment Lumira Ventures Nocion Therapeutics Chronic Cough Treatment Phase 2b Study Series B Financing
BRIEF published on 04/02/2024 at 13:05, 1 year 10 months ago Lumira Ventures investit dans Nocion Therapeutics pour faire progresser le traitement de la toux chronique Lumira Ventures Financement De Série B Nocion Thérapeutique Traitement De La Toux Chronique Étude De Phase 2b
PRESS RELEASE published on 04/02/2024 at 13:00, 1 year 10 months ago Lumira Ventures Announces Investment in Nocion Therapeutics to Revolutionize Chronic Cough Treatment Lumira Ventures invests in Nocion Therapeutics' Taplucanium for Chronic Cough treatment. Series B funding of $70M secured from leading investors Series B Funding Lumira Ventures Nocion Therapeutics Taplucanium Chronic Cough
BRIEF published on 03/07/2024 at 13:05, 1 year 11 months ago Lumira Ventures Celebrates Team Promotions Ahead of International Women's Day Healthcare Innovation Gender Equality International Women's Day Lumira Ventures Team Promotions
Published on 02/20/2026 at 18:30, 20 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 3 hours 5 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 20 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 42 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 50 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 18:36, 14 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 19 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 50 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 50 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 09:28, 9 hours 22 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 22 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
